is a protein-tyrosine kinase inhibitor, prescribed for treating certain type of cancers such as chronic myelogenous leukemia (cancer of the white blood cells, a
Imatinib indications
Imatinib is a protein-tyrosine kinase inhibitor, prescribed for treating certain type of cancers such as chronic myelogenous leukemia (cancer of the white blood cells, acute lymphoblastic leukemia(cancer of the white blood cells), gastrointestinal stromal tumors (tumors of the gastrointestinal tract and other cancers. It prevents the growth of cancer cells.
Imatinib dosage
PO- Dose varies from 400mg/day to 800mg/day depending on condition. 400 to 600mg/day should be administered once daily, 800mg/day, should be administered twice daily.
Imatinib usage
Available in the form tablets, to take by mouth (orally) with a meal and glass of water (8 oz/240 ml).
Imatinib precautions
Caution should be exercised in patients with history of high blood pressure, heart attack, irregular heartbeat, diabetes, heart, lung, thyroid or liver disease, smokers, street drug and heavy alcohol users. Avoid excess dosage. It may cause diarrhea during the treatment. Consult with your doctor if it does so. Consult with your doctor during pregnancy and breastfeeding.
Imatinib side effects
Heart- Compression of the heart, inflammation of the pericardium and blood clot. Central nervous System- Loss of strength, fatigue/lethargy, flu like symptoms, headache, dizziness, depression, sleeplessness, anxiety, decreased tactile sensibility, tingling, weakness, CNS hemorrhage and swelling of the brain. Skin- Rash/desquamation, itching, baldness, sweating, dry skin, redness of the skin and flushing. Eye and ENT- Eye edema, inflammation of the nose and pharynx, increased tears, pharynx and the esophagus pain, runny nose, blurred vision, bleeding in conjunctiva, dry eye and eyelid swelling. Gastrointestinal- Nausea, dry mouth, gastritis, loss of appetite, difficulty in swallowing, gastro esophageal reflux, GI bleeding, gas, intestinal obstruction, diarrhea, vomiting, abdominal pain, constipation, flatulence, abdominal distention and tumor hemorrhage/tumor necrosis. ♦ Blood-Bleeding, decrease in white blood cells, platelets, hemoglobin, subdural hematoma (SDH).
Imatinib warning
Avoid excess dosage. It may affect blood-clot, avoid unusual bruising or injury.
Imatinib storage conditions
Store at 25°C. Keep in airtight container. Keep away from children. ♦ Safety Labeling Changes Approved By FDA
Active ingredients: Imatinib
Compare prices at online shops
Strength
Quantity
Price, USD
Country
Get Canadian Drugs
400 mg
90
$1.00
Canada, Mauritius, Singapore, Turkey, UK, USA
North-West Pharmacy
100 mg
10
$109.99
Canada, Mauritius, Singapore, Turkey, UK, USA
BBG Fulfillment Ltd
100 mg
30
$260.00
Australia, Canada, Mauritius, NZ, Singapore, Turkey, UK, USA
400 mg
30
$329.00
Australia, Canada, Mauritius, NZ, Singapore, Turkey, UK, USA
"Bkj8m8g5hi: the unique ingredient identifier (unii) is an alphanumeric substance identifier from the joint fda/usp substance registration system (srs).". https://www.fda.gov/ForIndustry/Dat... (accessed August 28, 2018).
Imatinib - Frequently asked Questions
Can Imatinib be stopped immediately or do I have to stop the consumption gradually to ween off?
In some cases, it always advisable to stop the intake of some medicines gradually because of the rebound effect of the medicine.
It's wise to get in touch with your doctor as a professional advice is needed in this case regarding your health, medications and further recommendation to give you a stable health condition.
Can Imatinib be taken or consumed while pregnant?
Please visit your doctor for a recommendation as such case requires special attention.
Can Imatinib be taken for nursing mothers or during breastfeeding?
Kindly explain your state and condition to your doctor and seek medical advice from an expert.
Reviews
Following the study conducted by gmedication.com on Imatinib, the result is highlighted below. However, it must be clearly stated that the survey and result is based solely on the perception and impression of visitors and users of the website as well as consumers of Imatinib. We, therefore, urge readers not to base their medical judgment strictly on the result of this study but on test/diagnosis duly conducted by a certified medical practitioners or physician.
Patient reports
Patient reported useful
No survey data has been collected yet
Patient reported side effects
No survey data has been collected yet
Patient reported price estimates
No survey data has been collected yet
Patient reported frequency of use
No survey data has been collected yet
Patient reported doses
No survey data has been collected yet
Patient reported time for results
No survey data has been collected yet
Patient reported administration
No survey data has been collected yet
Patient reported age
No survey data has been collected yet
Patient reviews
There are no reviews yet. Be the first to write one!